Please refer to our Privacy policy for important information on the use of cookies. By continuing to use this website, you agree to this.

Press Release

Interserve wins contract for new £38m National Biologics Manufacturing Centre

by Interserve Press Office | Mar 12, 2014

Interserve, the international support services and construction group, has been awarded a design and build contract by The Centre for Process Innovation (CPI) for the new National Biologics Manufacturing Centre (NBMC).

The centre will be a large, open access facility that will help companies of all sizes to develop, prototype and scale up the next generation of biologic products, processes and technology. The scheme is part of the government’s strategy for Life Sciences, which will help UK companies to develop a competitive foothold in the growing biologics market.

Located at Central Park, Darlington, the centre will support the commercialisation of research by promoting collaboration between academia, the National Health Service and industry. The aim of the centre is to boost the UK pharmaceutical industry and supply chain in the rapidly growing biologics market, and increase the manufacturing capability for products developed in Britain. 

The centre will provide flexible laboratory areas for process, analytical and technology development as well as clean rooms and open-plan areas where new concepts can be tested. The NBMC will also offer offices, meeting rooms and spaces for training and conferencing.

Work is expected to start on site in April 2014, with completion expected by the end of March 2015.

CPI’s Dr Chris Dowle, Director of the NBMC said:

“We are pleased to have Interserve on board in delivering our new national centre and as part of the team. This contract will create new jobs for the region, helping to boost the local economy as well as delivering a state of the art centre to boost the competitiveness of the UK biologics sector.”

David Flewker, Regional Director at Interserve added:

“We are delighted to be involved in the delivery of the National Biologics Manufacturing Centre.  We have operated in the Tees Valley for nearly 60 years, and this strategically important facility will enhance the reputation and status of the region as a world leader in this field.”

- Ends -

For further information please contact:

Interserve Twyford Press Office
0118 932 0123

Karen Lewis or Peter Haddock
Edson Evers
01785 255146
karen@edsonevers.com or peter@edsonevers.com

About Interserve

Interserve's vision is to redefine the future for people and places. It is one of the world’s foremost support services and construction companies, operating in the public and private sectors in the UK and internationally, offering advice, design, construction, equipment, facilities management and front-line services. Interserve is based in the UK and is listed in the FTSE 250 index. The Group employs some 50,000 people worldwide and in 2013 generated gross revenue of £2.6 billion.

www.interserve.com
For all news follow: @interservenews

About CPI

The Centre for Process Innovation is a UK-based technology innovation centre and part of the High Value Manufacturing Catapult. It uses applied knowledge in science and engineering combined with state of the art development facilities to enable clients to develop, prove, prototype and scale up the next generation of products and processes.

www.uk-cpi.com

Share this


Latest Insight





Opportunities for all - Ex-service Personnel
Discover


SustainAbility
Our SustainAbilities journey

Watch our animation sharing the highlights from the fourth year of progress against Interserve’s SustainAbilities Plan.

Discover
Latest Insight





Opportunities for all - Ex-service Personnel
Discover
Reduced construction waste by 21% across our global operations #ingenuityatwork
Publication 2017 half-year report Download